These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7136065)

  • 1. [The effectiveness of recent cephalosporins against urinary tract and wound infection bacteria including Pseudomonas aeruginosa].
    Ortel S
    Z Gesamte Hyg; 1982 Aug; 28(8):545-51. PubMed ID: 7136065
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemotherapy of urinary tract infections caused by Pseudomonas].
    Yoshida O; Nonomura M
    Nihon Rinsho; 1986 Dec; 44(12):2633-7. PubMed ID: 3546821
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental efficacy of apalcillin and cefpiramide compared with that of six other antipseudomonal agents in Pseudomonas aeruginosa burn infections.
    Fu KP; Vince T; Hung PP; Gregory JF
    Drugs Exp Clin Res; 1986; 12(4):303-6. PubMed ID: 3720518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cephacetrile--a new cephalosporin antibiotic.
    Hodson AH; Holloway WJ
    Int J Clin Pharmacol; 1973 Feb; 7(1):89-94. PubMed ID: 4699390
    [No Abstract]   [Full Text] [Related]  

  • 5. Efficacy of a novel injectable cephalosporin, Cefclidin, on the experimental complicated urinary tract infections with urinary stones caused by Pseudomonas aeruginosa and Proteus mirabilis.
    Satoh M; Munakata K; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1994 Aug; 40(8):689-94. PubMed ID: 7942366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Azlocilline and HR 756 in urosepsis and urinary tract infection with multiresistant pseudomonas and proteus morganii].
    Pils P; Schmidt P; Zazgornik J; Graninger W; Kopsa H; Balcke P; Schimatzek A
    Dtsch Med Wochenschr; 1979 Jan; 104(2):66-7. PubMed ID: 252458
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of chronic urinary tract infection in children. I. Propicillin-dicloxacillin combination for Pseudomonas aeruginosa infections.
    Daschner F; Adam D; Marget W
    Arzneimittelforschung; 1973 Jul; 23(7):929-32. PubMed ID: 4201444
    [No Abstract]   [Full Text] [Related]  

  • 8. [Wound infection of Pseudomonas etiology in traumatology and orthopedic patients].
    Sheina EP; Ruindezh TG; Arutcheva AA
    Ortop Travmatol Protez; 1979 Aug; (8):7-11. PubMed ID: 116182
    [No Abstract]   [Full Text] [Related]  

  • 9. [In vitro activity of a new cephalosporin--cefoperazone--against Enterobacteriaceae and Pseudomonas aeruginosa].
    Modde H
    Schweiz Med Wochenschr; 1981 Mar; 111(10):356-8. PubMed ID: 6452690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complicated urinary tract infection caused by Pseudomonas aeruginosa in a single institution (1999-2003).
    Shigemura K; Arakawa S; Sakai Y; Kinoshita S; Tanaka K; Fujisawa M
    Int J Urol; 2006 May; 13(5):538-42. PubMed ID: 16771722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of kasugamycin in urinary tract infection, especially against Pseudomonas aeruginosa].
    Tada S; Hakamada T; Mori O; Yamazaki Y
    Hinyokika Kiyo; 1968 Jan; 14(1):50-6. PubMed ID: 4971183
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cephalosporins in the treatment of urinary tract infections].
    Ukhin AV
    Antibiot Khimioter; 1990 Aug; 35(8):43-5. PubMed ID: 2264755
    [No Abstract]   [Full Text] [Related]  

  • 13. Cephradine. Antibacterial activity and clinical effectiveness.
    Klastersky J; Daneau D; Weerts D
    Chemotherapy; 1973; 18(3):191-204. PubMed ID: 4684646
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical use of gentamicin in urinary tract infections due to Pseudomonas or Proteus].
    Shiba T; Ohashi N; Kamiya K; Fujieda J; Omuro H
    Hinyokika Kiyo; 1971 Sep; 17(9):601-4. PubMed ID: 5166131
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical effect of cephalexin for urinary tract infection].
    Masuda F; Minami T
    Hinyokika Kiyo; 1970 Aug; 16(8):413-6. PubMed ID: 5465839
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Carbenicillin. Current data on its use].
    Bertoye A; Woehrle R
    Lyon Med; 1971; 225():Suppl:137-41. PubMed ID: 5564793
    [No Abstract]   [Full Text] [Related]  

  • 18. Correlations between in vitro sensitivity testing and therapeutic response in urinary tract infections.
    Eudy WW
    Urology; 1973 Nov; 2(5):519-24. PubMed ID: 4588162
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of complicated urinary tract infection with cefoperazon].
    Rothenberger K; Hofstetter A; Friesen A
    Fortschr Med; 1981 Jan; 99(1-2):39-41. PubMed ID: 6451568
    [No Abstract]   [Full Text] [Related]  

  • 20. Ceftazidime as a single agent in the treatment of severe Pseudomonas aeruginosa infections.
    Clumeck N; Gordts B; Dab I; Jaspar N; Van Laethem Y; Butzler JP
    J Antimicrob Chemother; 1983 Jul; 12 Suppl A():207-11. PubMed ID: 6352620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.